As the technological frontier expands, it is possible that whole genome sequencing may supplant newborn screening programs. Before doing so, there are many important questions:

• How will we make decisions about the use of this technology and how will we evaluate its use?

• Who decides which conditions will be screened for?

• What criteria and evidence will be used to decide which conditions to screen for?

• How will these programs be implemented?